HGI Capital Management’s CorMedix CRMD Stock Holding History

HGI Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-51,553	Closed	-$283K	–	42
2022 Q1	$283K	Buy	51,553 +1,445	+3%	+$6.62K	0.09%	64
2021 Q4	$228K	Sell	50,108 -2,148	-4%	-$10.7K	0.08%	70
2021 Q3	$243K	Buy	52,256 +2,570	+5%	+$15K	0.1%	64
2021 Q2	$341K	Buy	49,686 +16,479	+50%	+$131K	0.12%	72
2021 Q1	$332K	Sell	33,207 -709	-2%	-$7.46K	0.14%	59
2020 Q4	$252K	Buy	+33,916	New	+$231K	0.12%	55

Other funds holding CRMD

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HGI Capital Management's CRMD Position: Q2 2022 in Review

HGI Capital Management sold out of CorMedix (CRMD) in Q2 2022, closing a stake of 51,553 shares — an estimated $283K sold.

HGI Capital Management first reported a position in CRMD in Q4 2020 and held it in 6 quarters. The position peaked at $341K in Q2 2021. 74 funds tracked by Wall St. Rank hold CRMD as of Q2 2022.

HGI Capital Management reported no remaining CorMedix position as of Q2 2022 after selling out during the quarter.
HGI Capital Management sold 51,553 CorMedix shares in Q2 2022, an estimated $283K.
HGI Capital Management first reported a position in CorMedix in Q4 2020 and held it in 6 quarters.
HGI Capital Management's CorMedix position peaked at $341K in Q2 2021.
74 funds tracked by Wall St. Rank held CorMedix as of Q2 2022.

Based on HGI Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.